Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 2/20 | 0.52 |
| ▸ | PTGS2 | P35354 | 6/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.50 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.48 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.46 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | TYR | P14679 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9720714 | 0.93 | MAOB (0.49) | ENPP2PTGS2CYP2A6AKR1C3AKR1C2 | |
| SCHEMBL4715345 | 0.93 | PTGS2 (0.53) | ENPP2PTGS2CYP2A6AKR1C3 | |
| Benzaldehyde SCHEMBL28192263 | 0.91 | ALDH1A1 (0.58) | PTGS2CYP2A6AKR1C3AKR1C2AKR1C1 | |
| SCHEMBL3923767 | 0.88 | ALDH1A1 (0.50) | ENPP2PTGS2CYP2A6AKR1C3ALDH1A1 | |
| SCHEMBL10649369 | 0.88 | PTGS2 (0.49) | ENPP2PTGS2AKR1C3MAOB | |
| SCHEMBL13926394 | 0.82 | CYP2A6 (0.52) | CYP2A6ALDH1A1TYRCYP2A13 | |
| SCHEMBL9720723 | 0.82 | MAOB (0.55) | ENPP2PTGS2AKR1C3AKR1C2AKR1C1 | |
| SCHEMBL9720721 | 0.82 | MAOB (0.55) | ENPP2PTGS2AKR1C3AKR1C2AKR1C1 | |
| SCHEMBL22118701 | 0.81 | CYP2A6 (0.46) | ENPP2CYP2A6ALDH1A1TYRCYP2A13 | |
| SCHEMBL30673256 | 0.81 | CYP2A6 (0.46) | PTGS2CYP2A6ALDH1A1TYRCYP2A13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1616 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120157695-A | Aza-BODIPY photosensitizers with diformyl groups, synthesis and PDT/PTT combined therapy application | 北京化工大学 | 2025-06-17 | — | — | CN | claimed |
| CN-120058569-A | Preparation method of p-methylsulfonyl benzaldehyde | 湖北武荆化工新材料有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-119219504-B | Method for synthesizing triarylmethane molecular skeleton by aromatic aldehyde and hydrazine hydrochloride substance | 山东金科力电源科技有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-119591527-A | Method for preparing florfenicol intermediate through chiral auxiliary-mediated asymmetric aldol reaction | 江苏恒盛药业有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-119570769-A | L-threonine aldolase mutant and application thereof in catalytic synthesis of p-methylsulfonyl phenylserine | 武汉大学 | 2025-03-07 | — | — | CN | claimed |
| CN-119506367-A | Method for preparing florfenicol intermediate by double-enzyme system | 上海昱菘生物科技有限公司 | 2025-02-25 | — | — | CN | claimed |
| US-20250059574-A1 | METHODS FOR PREPARING (2S,3R)-P-METHYLSULFONYLPHENYLSERINE | TAIZHOU UNIVERSITY (CN) | 2025-02-20 | — | — | US | claimed |
| CN-119219504-A | Method for synthesizing triarylmethane molecular skeleton by aromatic aldehyde and hydrazine hydrochloride substance | 山东金科力电源科技有限公司 | 2024-12-31 | — | — | CN | claimed |
| CN-119101091-A | DOPO-based phosphorus-nitrogen-sulfur synergistic flame retardant compound and preparation method and application thereof | 常州大学 | 2024-12-10 | — | — | CN | claimed |
| CN-118497167-B | L-threonine transaldolase mutant and application thereof in synthesis of L-p-methylsulfonylbenzylserine | 浙江昊清生物科技有限公司 | 2024-11-22 | — | — | CN | claimed |
| US-20030216454-A1 | Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same | CJ CHEILJEDANG CORPORATION (KR) | 2003-11-20 | — | — | US | claimed |
| US-6635090-B1 | Dyeing method using a specific cationic derivative and a compound selected among a specific aldehyde, a specific ketone, a quinone and a di-imino-isoindoline or 3-amino-isoindolone derivative | L'OREAL, S.A. (FR) | 2003-10-21 | — | — | US | claimed |
| CN-1389458-A | P-methylsulfonyl phenylacrylic acid derivative and preparation method and anti-inflammatory effect thereof | UNIV CHINA PHARMACY (CN) | 2003-01-08 | — | — | CN | claimed |
| US-6458168-B1 | Hair dyeing method using an aliphatic cationic amine and compound chosen from an aldehyde, a ketone, a quinone, a di-imino-isoindoline, and a 3-aminoisoindolone derivative | L'OREAL S.A. (FR) | 2002-10-01 | — | — | US | claimed |
| US-6451067-B1 | HAIR DYE MIXTURE | L'OREAL S.A. (FR) | 2002-09-17 | — | — | US | claimed |
| US-4916128-A | Thiadiazinones | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1990-04-10 | — | — | US | claimed |
| US-4696913-A | Novel peptides which are active on the central nervous system and have an action on the cholinergic system | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-09-29 | — | — | US | claimed |
| US-4623715-A | ANTIDEPRESSANTS | HOECHST AKTIENGESELLESCHAFT (DE) | 1986-11-18 | — | — | US | claimed |
| EP-0179332-A2 | ZNS-active peptides acting on the cholinergetic system | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-04-30 | — | — | EP | claimed |
| US-4118232-A | Photographic material containing sulphonic acid group containing disazo dyestuffs | CIBA-GEIGY AG (CH) | 1978-10-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030216454-A1 | Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same | SLC5A1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, NAT1 | ENPP2 4884/4885PTGS2 3143/4885CYP2A6 465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.